FDA Inspection
Ajinomoto Althea, Inc.Ajinomoto Althea, Inc. – FDA Inspection, Sep 20, 2023
Record Details
This FDA Inspection record concerns Ajinomoto Althea, Inc., with an inspection on September 20, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 472df7e1-0e55-4e82-8c44-be705c8e0aa1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1218719
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Ajinomoto Althea, Inc.
16| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | VAI | Los Angeles District Office | Drug Quality Assurance |
| February 9, 2023 | Not classified | Los Angeles District Office | |
| January 16, 2023 | Not classified | Los Angeles District Office | |
| May 25, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2019 | NAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Ajinomoto Althea, Inc.
- FDA Inspection 1266794 - 2025-05-09
- FDA Inspection 1223371 - 2023-02-09
- FDA Inspection 1195170 - 2023-01-16
- FDA Inspection 1142663 - 2021-05-25
- FDA Inspection 1108335 - 2019-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.